First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial
在 HIV 感染儿童中，一线抗逆转录病毒疗法采用蛋白酶抑制剂与非核苷类逆转录酶抑制剂的比较，以及在病毒载量较高时与较低时转换治疗方案的比较：一项开放标签、随机 II/III 期试验
期刊:Lancet Infectious Diseases
影响因子:31
doi:10.1016/S1473-3099(10)70313-3
Babiker, Abdel; Castro nee Green, Hannah; Compagnucci, Alexandra; Fiscus, Susan; Giaquinto, Carlo; Gibb, Diana M; Harper, Lynda; Harrison, Linda; Hughes, Michael; McKinney, Ross; Melvin, Ann; Mofenson, Lynne; Saidi, Yacine; Smith, M Elizabeth; Tudor-Williams, Gareth; Walker, A Sarah
